Meliha Meriç Koç
- Molecular Medicine top 5%
- Internal Medicine top 10%
- Virology top 10%
-
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 4
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
- HIV/AIDS Research and Interventions 4
-
- Hepatitis C virus research 7
-
- Bacillus and Francisella bacterial research 5
-
- Blood Pressure and Hypertension Studies 4
Meliha Meriç Koç
61 papers receiving 698 citations
Peers
Comparison fields: 5 of 103
- Applied Microbiology and Biotechnology 44
- Molecular Medicine 82
- Internal Medicine 57
- Virology 64
- Critical Care and Intensive Care Medicine 70
Countries citing papers authored by Meliha Meriç Koç
This map shows the geographic impact of Meliha Meriç Koç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meliha Meriç Koç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meliha Meriç Koç more than expected).
Fields of papers citing papers by Meliha Meriç Koç
This network shows the impact of papers produced by Meliha Meriç Koç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meliha Meriç Koç. The network helps show where Meliha Meriç Koç may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meliha Meriç Koç, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2020 | 5 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 15 | |
| 7 | 2019 | 26 | |
| 8 | 2009 | 7 | |
| 9 | 2008 | 28 | |
| 10 | 2008 | 63 | |
| 11 | 2007 | 5 | |
| 12 | 2006 | 2 | |
| 13 | 2006 | 52 | |
| 14 | 2005 | 17 | |
| 15 | [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors]. | 2004 | 14 |
| 16 | 2004 | 24 | |
| 17 | Hastanede yatan hastalardan izole edilen enterokok türleri ve antibiyotiklere direnç durumu | 2004 | 2 |
| 18 | 2004 | 8 | |
| 19 | 1998 | 17 | |
| 20 | 1989 | 1 |
About Meliha Meriç Koç
Meliha Meriç Koç is a scholar working on Virology, Infectious Diseases, Hepatology, Endocrinology and Epidemiology, having authored 66 papers that have together received 745 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), COVID-19 Clinical Research Studies (7 papers), Hepatitis C virus research (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Bacillus and Francisella bacterial research (5 papers), Blood Pressure and Hypertension Studies (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (44 citations), Molecular Medicine (82 citations), Internal Medicine (57 citations), Virology (64 citations) and Critical Care and Intensive Care Medicine (70 citations). Meliha Meriç Koç has collaborated with scholars based in Türkiye, Germany and Antigua and Barbuda. Frequent co-authors include Ayşe Willke, Murat Sayan, Çiğdem Çağlayan, Suna Gedikoğlu, E.-J. Finke, Mehmet Keşkek, Roland Grunow, Mesut Tez, Erdal Göçmen and Tamer Ertan. Their work appears in journals such as International Journal of STD & AIDS, Apmis, Journal of Medical Microbiology, Journal of Cardiovascular Pharmacology and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.